TSS
GCTK icon

Two Sigma Securities’s GlucoTrack GCTK Stock Holding History

Two Sigma Securities’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$3.48K – 3183
2023
Q4 		$3.48K Sell
2
-1
-33% -$1.33K ﹤0.01% 2909
2023
Q3 		$5.3K Hold
3
– – ﹤0.01% 2783
2023
Q2 		$6.57K Buy
+3
New +$10.8K ﹤0.01% 2644

Other funds holding GCTK

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
VCM
Virtue Capital Management Brentwood, Tennessee $657M AUM 24.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Securities's GCTK Position: Q1 2024 in Review

Two Sigma Securities sold out of GlucoTrack (GCTK) in Q1 2024, closing a stake of 2 shares — an estimated $3.48K sold.

Two Sigma Securities first reported a position in GCTK in Q2 2023 and held it in 3 quarters. The position peaked at $6.57K in Q2 2023. 7 funds tracked by Wall St. Rank hold GCTK as of Q1 2024.

  • Two Sigma Securities reported no remaining GlucoTrack position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 2 GlucoTrack shares in Q1 2024, an estimated $3.48K.
  • Two Sigma Securities first reported a position in GlucoTrack in Q2 2023 and held it in 3 quarters.
  • Two Sigma Securities's GlucoTrack position peaked at $6.57K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.